xylazine has been researched along with Acute Kidney Failure in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kapitsinou, PP | 1 |
Jaffe, J | 1 |
Michael, M | 1 |
Swan, CE | 1 |
Duffy, KJ | 1 |
Erickson-Miller, CL | 1 |
Haase, VH | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Roxadustat Reduces the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting: a Multicenter, Randomized, Double-blind, Placebo-controlled Study[NCT05010460] | Phase 2 | 318 participants (Anticipated) | Interventional | 2021-09-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for xylazine and Acute Kidney Failure
Article | Year |
---|---|
Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Hydroxylation; Hy | 2012 |